| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2021 | Dec 20, 2021 | Evofem Biosciences, Inc. | CFO | Buy | 86.3 | +40,594 | 9.22% | ✗ | $15K |
| Jun 10, 2021 | Jun 10, 2021 | Evofem Biosciences, Inc. | CFO | Buy | 86.3 | +24,500 | 5.89% | ✗ | $25.2K |
| May 20, 2021 | May 21, 2021 | Evofem Biosciences, Inc. | CFO | Sell | 46.3 | -42,280 | -9.23% | ✗ | $36.4K |
| Nov 17, 2020 | Nov 18, 2020 | Evofem Biosciences, Inc. | CFO | Buy | 83.8 | +7,760 | 3.10% | ✗ | $16.8K |
| Jun 12, 2020 | Jun 15, 2020 | Evofem Biosciences, Inc. | CFO | Buy | 83.8 | +8,500 | 3.51% | ✗ | $26.7K |
| Jun 5, 2020 | Jun 8, 2020 | Evofem Biosciences, Inc. | CFO | Sell | 42.5 | -42,810 | -15.27% | ✗ | $141.7K |
| May 22, 2020 | May 26, 2020 | Evofem Biosciences, Inc. | CFO | Sell | 42.5 | -42,262 | -13.10% | ✗ | $210.9K |
| May 6, 2020 | May 8, 2020 | Evofem Biosciences, Inc. | CFO | Sell | 46.3 | -8,420 | -2.54% | ✗ | $44.1K |
| Jan 13, 2020 | Jan 15, 2020 | Evofem Biosciences, Inc. | CFO | Sell | 52.5 | -1,648 | -0.92% | ✓ | $9.9K |
| Jan 2, 2020 | Jan 6, 2020 | Evofem Biosciences, Inc. | CFO | Sell | 48.8 | -3,352 | -1.84% | ✓ | $20.3K |
| Dec 2, 2019 | Dec 4, 2019 | Evofem Biosciences, Inc. | CFO | Sell | 32.5 | -10,000 | -5.20% | ✓ | $71.6K |
| Nov 25, 2019 | Nov 26, 2019 | Evofem Biosciences, Inc. | CFO | Sell | 42.5 | -10,102 | -4.99% | ✗ | $62.8K |
| Nov 20, 2019 | Nov 21, 2019 | Evofem Biosciences, Inc. | CFO | Sell | 32.5 | -15,102 | -6.94% | ✓ | $88K |
| Aug 22, 2019 | Aug 26, 2019 | Evofem Biosciences, Inc. | CFO | Sell | 50.0 | -1,558 | -0.71% | ✗ | $8K |
| Jun 10, 2019 | Jun 12, 2019 | Evofem Biosciences, Inc. | CFO | Sell | 42.5 | -10,185 | -4.44% | ✗ | $64.8K |
| Apr 1, 2019 | Apr 3, 2019 | Evofem Biosciences, Inc. | CFO | Sell | 50.0 | -1,292 | -0.56% | ✗ | $4.6K |
| Jul 2, 2018 | Jul 3, 2018 | Evofem Biosciences, Inc. | CFO | Sell | 97.5 | +180,490 | 100.00% | ✗ | $294K |